1. Study shows effectiveness of micropulse TSCPC for glaucoma
A five-year study investigating the use of micropulse transscleral cyclophotocoagulation (TSCPC) and how it affects intraocular pressure (IOP) in patients with glaucoma has been published in Ophthalmology and Therapy.
The authors judged micropulse TSCPC to be safe and effective as a treatment for reducing IOP and the number of IOP-lowering medications required. It was also deemed a viable alternative for patients after failed incisional glaucoma surgery.
Researchers conducted a retrospective analysis of 165 patients with glaucoma in the Netherlands between 2016 and 2019.
The study saw an IOP reduction or a stable postoperative IOP with fewer medications in 70.8% of patients after five years.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The GOC is consulting on an update to its 2013 Statement on the testing of sight, alongside proposed changes to the Standards of Practice for Optometrists and Dispensing Opticians and the Standards for Optical Students.
An overview of the background and current treatment options available for the macular diseases retinal vein occlusion, diabetic macular oedema and age-related macular degeneration.